Info
- Utilizzare la checkbox di selezione a fianco di ciascun documento per attivare le funzionalità di stampa, invio email, download nei formati disponibili del (i) record.
Atlas of Emergency Neurovascular Imaging [[electronic resource] /] / by Yang Tang
| Atlas of Emergency Neurovascular Imaging [[electronic resource] /] / by Yang Tang |
| Autore | Tang Yang |
| Edizione | [1st ed. 2020.] |
| Pubbl/distr/stampa | Cham : , : Springer International Publishing : , : Imprint : Springer, , 2020 |
| Descrizione fisica | 1 online resource (158 pages) |
| Disciplina | 616.0754 |
| Soggetto topico |
Emergency medicine
Radiology Emergency Medicine Imaging / Radiology Malalties cerebrovasculars Diagnòstic per la imatge Medicina d'urgència |
| Soggetto genere / forma | Llibres electrònics |
| ISBN | 3-030-43654-3 |
| Formato | Materiale a stampa  |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto | 1. Acute Stroke Imaging -- 2. Ischemic Stroke Vascular Territory -- 3. Imaging of Stroke Mimics -- 4. Cerebrovenous Thrombosis -- 5. Cerebral Vasculopathy: CNS Vasculitis, RCVS, and PRES -- 6. Miscellaneous Cerebral Vasculopathy -- 7. Traumatic Neurovascular Injury -- 8. Cerebral Aneurysm -- 9. Cerebral Vascular Malformations -- 10. Vascular Emergency of the Head and Neck -- 11. Spinal Vascular Diseases. |
| Record Nr. | UNINA-9910392734503321 |
Tang Yang
|
||
| Cham : , : Springer International Publishing : , : Imprint : Springer, , 2020 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Clinical Child Neurology [[electronic resource] /] / edited by Mustafa A.M. Salih
| Clinical Child Neurology [[electronic resource] /] / edited by Mustafa A.M. Salih |
| Edizione | [1st ed. 2020.] |
| Pubbl/distr/stampa | Cham : , : Springer International Publishing : , : Imprint : Springer, , 2020 |
| Descrizione fisica | 1 online resource (1,423 pages) |
| Disciplina | 618.928 |
| Soggetto topico |
Neurology
Pediatrics Neurology Malalties cerebrovasculars Malalties cerebrals Malalties del sistema nerviós central Neurologia pediàtrica |
| Soggetto genere / forma | Llibres electrònics |
| ISBN | 3-319-43153-6 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto | Approach to status epilepticus -- Clinical features and management of childhood epileptic syndromes -- The genetics of childhood epilepsy: A clinical approach -- Management of neonatal and infantile seizures -- Management of refractory childhood epilepsy and epilepsy surgery -- New treatments for childhood epilepsy -- Neurodevelopment and social impact of childhood epilepsy -- Diseases of the lower motor unit -- Standards of care for childhood neuromuscular disorders -- Neuroinfections in childhood -- Neurological aspects of neglected tropical diseases -- Childhood neuroinflammatory disorders -- Childhood neurodegenerative disorders (ataxias and hereditary spastic paraplegia) -- Movement disorders in childhood -- Childhood neuro-ophthalmic disorders -- Traumatic brain injury and disorders of intracranial pressure in children -- Cerebrovascular disease in children -- Tumors of the brain and spine, and paraneoplastic disorders in childhood -- Pain management, palliative care and ethical issues in child neurology. |
| Record Nr. | UNINA-9910407729203321 |
| Cham : , : Springer International Publishing : , : Imprint : Springer, , 2020 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
IschemiRs: MicroRNAs in Ischemic Stroke [[electronic resource] ] : From Basics to Clinics / / by Rajanikant G. K., Pierre Gressens, Sreekala S. Nampoothiri, Gokul Surendran, Cindy Bokobza
| IschemiRs: MicroRNAs in Ischemic Stroke [[electronic resource] ] : From Basics to Clinics / / by Rajanikant G. K., Pierre Gressens, Sreekala S. Nampoothiri, Gokul Surendran, Cindy Bokobza |
| Autore | G. K Rajanikant |
| Edizione | [1st ed. 2020.] |
| Pubbl/distr/stampa | Singapore : , : Springer Singapore : , : Imprint : Springer, , 2020 |
| Descrizione fisica | 1 online resource (146 pages) |
| Disciplina | 616.81 |
| Soggetto topico |
Neurosciences
Human genetics Immunology Apoptosis Oxidative stress Human Genetics Oxidative Stress Malalties cerebrovasculars RNA Expressió gènica |
| Soggetto genere / forma | Llibres electrònics |
| ISBN | 981-15-4798-X |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto | Preface -- Chapter 1: microRNAs in normal brain physiology -- Chapter 2: Ischemic stroke: An imperative need for effective therapy -- Chapter 3: MicroRNAs in ischemic stroke pathophysiology: Special emphasis on early molecular events -- Chapter 4: microRNA regulation of ischemic stroke inflammatory and immune response -- Chapter 5: Regulatory role of microRNAs in ischemic cell death -- Chapter 6: The emerging role of microRNAs in post-ischemic angiogenesis and neurogenesis -- Chapter 7: MicroRNAs as potential diagnostic, prognostic and therapeutic biomarkers in ischemic stroke -- Chapter 8: Interplay between microRNAs and other cerebrovascular diseases -- Chapter 9: New insights into the regulatory role of lncRNA, circRNA, piRNAs, and ceRNAs in ischemic stroke -- Chapter 10: Computational resources for microRNA research -- Chapter 11: MicroRNA-targeted therapeutics for ischemic stroke: Status, gaps and the way forward. |
| Record Nr. | UNINA-9910409685703321 |
|
G. K Rajanikant
|
||
| Singapore : , : Springer Singapore : , : Imprint : Springer, , 2020 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Models and techniques in stroke biology / / Amit Kumar Tripathi, Abhishek Kumar Singh, editors
| Models and techniques in stroke biology / / Amit Kumar Tripathi, Abhishek Kumar Singh, editors |
| Pubbl/distr/stampa | Singapore : , : Springer, , [2021] |
| Descrizione fisica | 1 online resource (vii, 115 pages) : illustrations |
| Disciplina | 574.028 |
| Soggetto topico |
Biology - Technique
Malalties cerebrovasculars Models biològics Manuals de laboratori |
| Soggetto genere / forma | Llibres electrònics |
| ISBN | 981-336-679-6 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
Intro -- Contents -- About the Editors -- Chapter 1: Rodent Stroke Model Guidelines: An Update -- 1.1 Introduction -- 1.2 The General Guideline for a Rodent Model for Stroke -- 1.3 STAIR Committee, Recommendations, and Guidelines -- 1.4 Intraluminal Model -- 1.5 Different Types of the Occluder and their Success Rate -- 1.6 PLL-Coated Occluders -- 1.7 Flame Blunted Occluders -- 1.8 Silicone-Rubber Coated Occluders -- 1.9 An Optimization Technique for Intraluminal Inserting Occluders -- 1.10 Optimization of Surgical Procedure -- 1.11 The Tamura Method of a Stroke Model -- 1.12 Infarction Area Estimation -- 1.13 Methods for Infarction Visualization -- 1.14 Direct Image of Infarction in Fresh Brain Sections Stained with TTC Solution -- 1.15 Digital Method for Defining the Infarction -- 1.16 Calculation of Infarction Volume -- 1.17 Preparation of Stroke Surgical Procedure -- 1.18 Koizumi´s Suture Method -- 1.19 Longa´s MCAO Method -- 1.20 Neurobehaviour Assessment of Functional Recovery -- 1.21 Assessment of Neurological Functional Outcomes -- 1.21.1 Composite Score -- 1.21.1.1 Bederson Scale and Neurological Deficit Scoring -- 1.21.1.2 Modified Neurological Severity Score -- 1.21.2 Motor Tests -- 1.21.2.1 Cylinder Test -- 1.21.2.2 Ledged Tapered Beam Test -- 1.21.2.3 Pellet Retrieval Task -- 1.21.3 Sensorimotor Test -- 1.21.3.1 Forelimb Flexion -- 1.21.3.2 Forelimb Placing -- 1.21.3.3 Accelerated Rotarod Test -- 1.21.3.4 Adhesive Removal Test -- 1.22 Anesthetics -- 1.23 Monitoring and Maintaining the Core Brain Temperature -- 1.24 Mechanical Ventilation, Blood Gases, Glucose, and Blood Pressure Monitoring -- 1.25 Pilot Study Plan and Implementation of a Preclinical Stroke Trial -- 1.26 Application of the Suitable Statistical Method for Data Analysis -- 1.27 Standard Operating Procedures for Creating a Stroke Model.
1.28 Conclusion and Future Direction -- References -- Chapter 2: Bilateral Common Carotid Artery Occlusion: Stroke Model -- 2.1 Introduction -- 2.2 Importance of BCCAO -- 2.3 Permanent BCCAO -- 2.4 Transient BCCAO -- 2.5 BCCAO Sham Surgery -- 2.6 Factors Affecting the BCCAO -- 2.6.1 Effect of Ischemic Preconditioning -- 2.7 Effect of ROS -- 2.8 Effect of Mitochondrial Dysfunction -- 2.9 Role of the Apoptotic Pathway -- 2.10 Effect of BCCAO Duration and Animal Model Sex -- 2.11 Effect on Blood-Brain Barrier -- 2.12 Effect of Oxygen Free Radicals -- 2.13 Conclusion -- References -- Chapter 3: Cerebral Venous Sinus Thrombosis Rodent Model -- 3.1 Introduction -- 3.2 Clinical Manifestation, Diagnosis, and Prognosis of CVST -- 3.3 Clinical Recommendation for Management of CVST Patients -- 3.4 Experimental CVST Model Protocol -- 3.5 Precautions -- 3.6 TTC Staining Technique -- 3.7 Neurological Evaluation -- 3.8 CVST as a Preclinical Model for Evaluation of Neuroprotective Agents -- References -- Chapter 4: A Non-human Primate Model for Cerebral Stroke -- 4.1 Introduction -- 4.2 Ischemia Model in NHPs -- 4.3 Major Advantages of NHPs Used as Stroke Model -- 4.4 Ethical Challenges -- 4.5 Permanent MCA Occlusion -- 4.6 Transient MCA Occlusion -- 4.7 Thrombus MCA Occlusion in NHPs -- References -- Chapter 5: Laser Doppler Flowmetry Recording for Rodent Stroke Model Confirmation -- 5.1 Introduction -- 5.2 Laser Doppler Flowmetry -- 5.3 Theory and Basic Principal Laser Doppler Flowmetry -- 5.4 Experimental Applications of Laser Doppler Flowmetry (LDF) -- 5.5 Advantages and Limitations of Laser Doppler Flow Meters -- 5.6 Conclusion -- References -- Chapter 6: Laser Speckle Imaging for Cerebral Ischemia and Reperfusion Injury -- 6.1 Introduction -- 6.2 Basic Principles of Laser Speckle Contrast Imaging -- 6.3 Application in Clinical and Biomedical Research. 6.3.1 Preclinical Application of LSCI in the Rodent Model of Cerebral Ischemic Stroke -- 6.3.2 Applications of LSCI in Stroke Induced Language Impairment -- 6.4 Limitations of the LSCI Technique -- 6.5 Conclusion and Recommendations -- References -- Chapter 7: Cerebrovascular Imaging in a Rodent Stroke Model -- 7.1 Introduction -- 7.2 Cerebrovascular Imaging -- 7.3 Cerebral Vessels Staining with a Combination of Carbon Black Inks -- 7.4 Assessment of Cerebral Vascular Network -- 7.5 Alternative Methods for Cerebral Vascular Anatomy -- 7.6 Current Challenges and Future Prospective -- References -- Chapter 8: Photothrombotic Stroke Model -- 8.1 Introduction -- 8.2 Induction of Photothrombotic Lesion -- 8.2.1 Surgery for Illumination of the Region of Interest -- 8.2.2 Injection and Activation of Rose Bengal -- 8.3 Assessment of Photothrombotic Lesion -- 8.4 Merits and Demerits of the Photothrombotic Stroke Model -- 8.5 Conclusion -- References. |
| Record Nr. | UNINA-9910484098603321 |
| Singapore : , : Springer, , [2021] | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Moyamoya disease : current knowledge and future perspectives / / Satoshi Kuroda, editor
| Moyamoya disease : current knowledge and future perspectives / / Satoshi Kuroda, editor |
| Pubbl/distr/stampa | Singapore : , : Springer, , [2021] |
| Descrizione fisica | 1 online resource (xv, 341 pages) : illustrations |
| Disciplina | 617.48 |
| Soggetto topico |
Nervous system - Surgery
Malalties cerebrovasculars Neurocirurgia |
| Soggetto genere / forma | Llibres electrònics |
| ISBN | 981-336-404-1 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
Intro -- Foreword -- Preface -- Contents -- Part I: Concept of Moyamoya Disease -- 1: History of Disease Entity and Diagnosis Criteria -- 1.1 Introduction -- 1.2 History of Moyamoya Disease -- 1.3 Diagnosis Criteria of Moyamoya Disease -- References -- 2: Moyamoya Syndrome -- 2.1 Terminology -- 2.2 Epidemiology -- 2.2.1 Japan -- 2.2.2 Taiwan -- 2.2.3 China -- 2.2.4 Korea -- 2.2.5 United States of America -- 2.2.6 Germany -- 2.3 Associated Conditions -- 2.3.1 Neurofibromatosis Type 1 (von Recklinghausen's Disease) -- 2.3.2 Down Syndrome (Trisomy 21) -- 2.3.3 Thyroid Disease -- 2.3.4 Sickle Cell Disease -- 2.3.5 Others -- 2.3.6 Acquired Conditions -- 2.4 Surgical Revascularization and Outcome -- 2.5 Future Perspectives in Diagnosis and Patient Care -- References -- 3: Unilateral Moyamoya Disease: A Distinct Entity? -- 3.1 Introduction -- 3.2 Definition of Unilateral Moyamoya Disease -- 3.3 Clinical and Radiological Features -- 3.4 Biomarkers -- 3.5 Differentiation of Moyamoya Disease from Non-moyamoya Arteriopathy, Including FCA -- 3.6 Contralateral Progression -- 3.7 PCA Involvement -- 3.8 Perspectives -- References -- Part II: Genetic Aspect of Moyamoya Disease -- 4: RNF213 as a Susceptibility Gene for Moyamoya Disease has Multifunctional Roles in Biological Processes -- 4.1 Introduction: RNF213 and Moyamoya Disease -- 4.2 Functional Properties of RNF213 and its Variants -- 4.2.1 Upregulation of RNF213 by Inflammatory Substances -- 4.2.2 Inhibitory Effects of RNF213 Variants on EC Functions and Cell Division -- 4.2.2.1 EC Dysfunction -- 4.2.2.2 Abnormal Mitosis -- 4.2.3 Stabilizing Effect of RNF213 on Cytoplasmic Lipid Droplets -- 4.2.4 NFκB Activation and Apoptosis by RNF213 Variants -- 4.2.5 Roles Played by RNF213 Domains and Variants -- 4.3 Susceptibilities Related to RNF213.
4.3.1 Hypoxia and Hypoperfusion -- 4.3.2 Endoplasmic Reticulum Stress in Diabetes -- 4.3.3 Lipotoxicity -- 4.4 Relationship with Infection and Immune Function in MMD -- 4.5 Conclusions and Perspectives -- References -- 5: RNF213 and Clinical Feature -- 5.1 Introduction -- 5.2 RNF213 p.R4810K Genotype-Phenotype Correlation in Moyamoya Disease in East Asia -- 5.2.1 Japan and Korea -- 5.2.2 China -- 5.3 The Other Rare Variants of RNF213 -- 5.4 RNF213 Variant in Caucasian -- 5.5 RNF213 and Diseases Other than Moyamoya Disease -- 5.6 Conclusion -- References -- 6: RNF213 Variant as a Biomarker of Cerebrovascular Disease -- 6.1 Ring Finger Protein 213 (RNF213) -- 6.2 RNF213 and Intracranial Artery Stenosis -- 6.3 Variants of RNF213 Other than p.Arg4810Lys Associated with ICAS -- 6.4 Features of ICAS with the RNF213 p.Arg4810Lys Variant -- 6.5 Associations of General Ischemic Stroke and the RNF213 p.Arg4810Lys Variant -- 6.6 Associations of Systemic Vascular Diseases with the RNF213 p.Arg4810Lys Variant -- 6.7 Functional Analysis of the RNF213 Gene -- 6.8 Future Perspectives and Issues -- References -- Part III: Pathophysiology of Moyamoya Disease -- 7: TIA and Headache in Pediatric Moyamoya Disease -- 7.1 Introduction -- 7.2 Transient Ischemic Attack -- 7.2.1 Clinical Features and Mechanism -- 7.2.2 Natural Course of TIA -- 7.3 Headache Attack -- References -- 8: Ischemic Stroke -- 8.1 Introduction -- 8.2 Symptomatology -- 8.3 Radiological Features: Locations and Collateral Flows -- 8.4 Cerebral Hemodynamic Compromise -- 8.4.1 Compensatory Mechanisms against Cerebral Perfusion Pressure Decrease -- 8.4.2 Evaluation of Cerebral Perfusion Pressure Decrease -- 8.5 Ivy Sign -- 8.6 Surgical Indications -- 8.7 Antiplatelet Therapy for Ischemic MMD -- References -- 9: Hemorrhagic Stroke and the Japan Adult Moyamoya Trial. 9.1 Introduction -- 9.2 The JAM Trial -- 9.3 Primary Results of the JAM Trial -- 9.4 Prespecified Subgroup Analysis of the JAM Trial -- 9.5 Mechanism of Bleeding in Moyamoya Disease: Periventricular Anastomosis -- 9.6 Why Does the Posterior Hemorrhage Group Have a Poor Natural Prognosis? -- 9.7 The Mechanism of Bypass Surgery in Preventing Hemorrhage -- 9.8 Additional Sub-analyses of the JAM Trial -- 9.9 Summary -- References -- 10: Cognitive Function in Pediatric Moyamoya Disease -- 10.1 Introduction -- 10.2 Clinical Features -- 10.3 Effects of Surgical Revascularization on Intellectual Outcome -- 10.4 Pathophysiology -- 10.5 Conclusion -- References -- 11: Cognitive Dysfunction in Adults -- References -- 12: Asymptomatic Moyamoya Disease -- 12.1 Introduction -- 12.2 Definition and Epidemiology -- 12.3 Radiological Findings -- 12.4 Natural Course -- 12.5 Asymptomatic Moyamoya Registry (AMORE) Study -- 12.6 Conclusion -- References -- Part IV: Update on Neuroradiology in Moyamoya Disease -- 13: Periventricular Anastomosis -- 13.1 Anatomy -- 13.2 Relationship between Periventricular Anastomosis and Bleeding -- 13.3 Radiological Findings -- 13.3.1 Lenticulostriate Anastomosis -- 13.3.2 Thalamic Anastomosis -- 13.3.3 Choroidal Anastomosis -- References -- 14: Arterial Shrinkage -- 14.1 Introduction -- 14.2 Arterial Shrinkage in Carotid Fork -- 14.3 Arterial Shrinkage in Posterior Cerebral Artery -- 14.4 Arterial Shrinkage in Moyamoya Syndrome -- 14.5 Clinical Significance of Arterial Shrinkage in Moyamoya Disease -- 14.5.1 Endovascular Treatment -- 14.5.2 Differential Diagnosis of Moyamoya Disease -- References -- 15: Disease Progression -- 15.1 Introduction -- 15.2 Suzuki's Angiographic Staging as an Intrinsic Temporal Nature of Physiological Compensatory Reorganization in MMD -- 15.3 Disease Progression in Adult MMD. 15.4 Significance of Progressive Stenosis in Posterior Cerebral Artery (PCA) -- References -- 16: Postoperative Hyperperfusion -- 16.1 Introduction -- 16.2 Incidence of HP -- 16.3 Clinical Features -- 16.4 Diagnosis -- 16.5 Intraoperative Evaluations -- 16.5.1 Indocyanine Green Videoangiography -- 16.5.2 Flow Meters -- 16.5.3 Caliber Mismatch of Donor and Recipient Arteries -- 16.5.4 Hemodynamic Sources of Recipient Arteries -- 16.6 Postoperative Imaging -- 16.6.1 SPECT/PET -- 16.6.2 MRI -- 16.7 3 MRA -- 16.8 Pathogenesis -- 16.9 Perioperative Management of HP -- References -- 17: Postoperative FLAIR Imaging Changes -- 17.1 Introduction -- 17.2 Radiological Features of the Hyperintense Signal -- 17.3 The Role of Cerebral Hemodynamics -- 17.3.1 Preoperative Cerebral Hemodynamics -- 17.3.2 Postoperative Hyperperfusion -- 17.4 Future Perspective -- References -- Part V: Real World of Surgical Revascularization for Moyamoya Disease -- 18: Overview of Surgical Revascularization and Long-Term Outcome in Japan -- 18.1 Introduction -- 18.2 Surgical Procedures -- 18.2.1 Indirect Bypass Surgery -- 18.2.2 Direct Bypass Surgery -- 18.2.3 Combined Bypass Surgery -- 18.3 Long-Term Outcome in Japan -- References -- 19: Perioperative Complications -- 19.1 Background -- 19.2 Frequency and Pathophysiology of Perioperative Complications -- 19.2.1 Classification -- 19.3 Perioperative Stroke -- 19.3.1 Ischemic Complications -- 19.4 Hemorrhagic Complications -- 19.4.1 Postoperative Hyperperfusion -- 19.5 Procedure-Related Complications -- 19.6 Perioperative Management to Prevent Complications -- 19.7 Discussion -- References -- 20: Long-Term Outcome in Europe -- 20.1 Moyamoya Disease in Europe: Overview -- 20.2 Surgical Treatment of Moyamoya Patients in our Institute -- 20.3 Long-Term Outcome of Moyamoya Patients in Europe. 20.4 Conclusion -- References -- 21: Long-Term Outcomes in the USA -- 21.1 Introduction -- 21.2 Epidemiology of Moyamoya Disease in the USA -- 21.3 Presentation -- 21.4 Natural History in the USA -- 21.5 Treatment Trends -- 21.6 Outcomes -- 21.7 Conclusions -- References -- 22: Long-Term Outcome in China -- 22.1 Introduction -- 22.2 Epidemiology -- 22.2.1 General Epidemiology -- 22.2.2 Genetic Epidemiology -- 22.3 Treating Modality -- 22.3.1 Revascularization -- 22.3.2 Varied Kinds of Revascularization -- 22.3.3 Modified Revascularization -- 22.4 Ischemic Moyamoya Disease in China and Its Long-Term Outcomes -- 22.4.1 Cognitive Status of MMD in China -- 22.4.2 Long-Term Outcomes of Ischemic MMD in China -- 22.4.2.1 Overall Outcomes -- 22.4.2.2 Neurocognitive and Neuroimaging Outcomes -- 22.5 Long-Term Outcomes in Hemorrhagic MMD -- 22.5.1 Natural History of Hemorrhagic MMD in China -- 22.5.2 Long-Term Outcome of Surgically Treated Hemorrhagic MMD in China -- 22.5.2.1 Direct Revascularization -- 22.5.2.2 Indirect Revascularization -- 22.5.2.3 Combined Revascularization -- 22.6 Long-Term Outcomes in Pediatric MMD -- 22.6.1 Treatments -- 22.6.2 Long-Term Clinical Outcome -- 22.7 Conclusion -- References -- 23: Long-Term Outcome of Revascularization Surgery for Moyamoya Disease in Korea -- 23.1 Introduction -- 23.2 Procedure of RVS -- 23.3 Indication of RVS -- 23.4 Selection of the RVS Procedure -- 23.5 Long-term Outcome of RVS for Patients with MMD in Korea (Table 23.1) -- 23.6 Conclusion -- References -- 24: Indirect Bypass Surgery for Moyamoya Disease -- 24.1 Introduction -- 24.2 History and Mechanism of Indirect Bypass Surgery -- 24.3 The Hemodynamic Characteristics of Moyamoya Disease -- 24.4 Pre-Operative Neuroimaging for Precise Application of Indirect-Bypass Surgery. 24.5 Surgical Procedure of Indirect Bypass Surgery. |
| Record Nr. | UNINA-9910483040803321 |
| Singapore : , : Springer, , [2021] | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Precision medicine in stroke / / Ana Catarina Fonseca, José M. Ferro, editors
| Precision medicine in stroke / / Ana Catarina Fonseca, José M. Ferro, editors |
| Edizione | [1st ed. 2021.] |
| Pubbl/distr/stampa | Cham, Switzerland : , : Springer, , [2021] |
| Descrizione fisica | 1 online resource (VIII, 339 p. 74 illus., 30 illus. in color.) |
| Disciplina | 616.81 |
| Soggetto topico |
Cerebrovascular disease
Malalties cerebrovasculars |
| Soggetto genere / forma | Llibres electrònics |
| ISBN | 3-030-70761-X |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto | Part 1: Precision Medicine -- Introduction -- Precision Medicine:enabling health care progresso in the 21stcentury -- Do we need precision medicine in stroke -- Part 2: Current applications of precision medicine in Ischemic stroke -- monogenic diseases -- Pharmacodynamics and pharmacokinetics of stroke therapy -- Acute stroke imaging -- Part 3: Current applications of precision medicine in Haemorrhagic stroke -- Intracerebral haemorrhage -- Part 4: Future application -- Blood protein biomarkers in the diagnosis of stroke -- prognosis determination -- Part 5: Interdisciplinary approach -- Artificial intelligence applications in stroke -- Registry-based stroke research -- From bedside to bench: methods in precision medicine -- Approach for genetic studies -- Part 6: Conclusion -- Precision medicine versus personalized medicine. |
| Record Nr. | UNINA-9910483503903321 |
| Cham, Switzerland : , : Springer, , [2021] | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Recent progress in the management of cerebrovascular diseases : treatment strategies, techniques and complication avoidance / / edited by Yoko Kato
| Recent progress in the management of cerebrovascular diseases : treatment strategies, techniques and complication avoidance / / edited by Yoko Kato |
| Pubbl/distr/stampa | Singapore : , : Springer, , [2021] |
| Descrizione fisica | 1 online resource (170 pages) |
| Disciplina | 370.1523 |
| Soggetto topico |
Nervous system - Surgery
Malalties cerebrovasculars Neurocirurgia |
| Soggetto genere / forma | Llibres electrònics |
| ISBN | 981-16-3387-8 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Record Nr. | UNINA-9910495237103321 |
| Singapore : , : Springer, , [2021] | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Stroke research and treatment
| Stroke research and treatment |
| Pubbl/distr/stampa | London, : Sage-Hindawi Access to Research |
| Soggetto topico |
Cerebrovascular disease
Stroke Cerebrovascular Disorders Malalties cerebrovasculars Malalties cerebrals |
| Soggetto genere / forma |
Periodical
Fulltext Internet Resources. Periodicals. Revistes electròniques. |
| Soggetto non controllato | Neurology |
| ISSN | 2042-0056 |
| Formato | Materiale a stampa |
| Livello bibliografico | Periodico |
| Lingua di pubblicazione | eng |
| Record Nr. | UNISA-996204865803316 |
| London, : Sage-Hindawi Access to Research | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. di Salerno | ||
| ||
Stroke research and treatment
| Stroke research and treatment |
| Pubbl/distr/stampa | London, : Sage-Hindawi Access to Research |
| Soggetto topico |
Cerebrovascular disease
Stroke Cerebrovascular Disorders Malalties cerebrovasculars Malalties cerebrals |
| Soggetto genere / forma |
Periodical
Fulltext Internet Resources. Periodicals. Revistes electròniques. |
| Soggetto non controllato | Neurology |
| ISSN | 2042-0056 |
| Formato | Materiale a stampa |
| Livello bibliografico | Periodico |
| Lingua di pubblicazione | eng |
| Record Nr. | UNINA-9910140629003321 |
| London, : Sage-Hindawi Access to Research | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Stroke revisited : dyslipidemia in stroke / / Seung-Hoon Lee, Min Kyoung Kang, editors
| Stroke revisited : dyslipidemia in stroke / / Seung-Hoon Lee, Min Kyoung Kang, editors |
| Pubbl/distr/stampa | Singapore : , : Springer, , [2021] |
| Descrizione fisica | 1 online resource (219 pages) |
| Disciplina | 616.81 |
| Collana | Stroke revisited |
| Soggetto topico |
Cerebrovascular disease
Malalties cerebrovasculars |
| Soggetto genere / forma | Llibres electrònics |
| ISBN | 981-16-3923-X |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Record Nr. | UNINA-9910495249703321 |
| Singapore : , : Springer, , [2021] | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
